logo-top-r-w
  • HOME
  • ABOUT MORSE
    • The Team
    • Careers
  • SERVICES
    • Our Services
      • Comprehensive Market Access Launch Strategy
      • Market Access Landscape Analysis
      • HTA Planning and Reimbursement Evidence Strategy
      • Negotiation & Stakeholder Engagement Strategy
      • Portfolio & Life Cycle Strategy
      • Expert-Led Training & Customized Workshops
  • REPORTS
    • NEW – Order CRaFT 2025
    • DRD Market Access Trends & Insights
    • Oncology Market Access Trends & Insights
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
    • From Model to Market (MORSE x CCX Workshop)
  • LINKS
  • CONTACT US
logo-top-r
logo-top-r-w
  • HOME
  • ABOUT MORSE
    • The Team
    • Careers
  • SERVICES
    • Our Services
      • Comprehensive Market Access Launch Strategy
      • Market Access Landscape Analysis
      • HTA Planning and Reimbursement Evidence Strategy
      • Negotiation & Stakeholder Engagement Strategy
      • Portfolio & Life Cycle Strategy
      • Expert-Led Training & Customized Workshops
  • REPORTS
    • NEW – Order CRaFT 2025
    • DRD Market Access Trends & Insights
    • Oncology Market Access Trends & Insights
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
    • From Model to Market (MORSE x CCX Workshop)
  • LINKS
  • CONTACT US

MORSE Consulting Releases its pCPA Quarterly Update – Q3 2023

October 19, 2023
-
Market Access News, Publications
-
Posted by MORSE - < 1 min read.
MORSE Consulting Inc. is pleased to release our pCPA Quarterly Update infographic highlighting key metrics from Q3 2023 compared to performance over the last year. For a more in-depth look at market access trends and timelines comparing 2022 data to that of the past four years, order MORSE Consulting’s Canadian Reimbursement and Forecasting Timelines (CRaFT) report.

 

Click on graphic to print or see full-size OR download PDF.

 

Please contact info@morseconsulting.ca regarding any questions on this infographic or on the CRaFT report.

Embed this infographic (copy and paste code) on your website with attribution:

 

To receive updates similar to this one, please sign up for MORSE Signals, our free e-mail newsletter service.

Share
Tags
Biosimilars
CADTH
COVID-19
CRaFT
DRD
Forecasting
Market Access
Oncology
Pan Canadian Pharmaceutical Alliance
Pandemic
pCPA
pCPAO
Reimbursement
← PREVIOUS POST
Challenges and Success with Win-Win-Win-Win Negotiations - Fall 2023 CORD Conference
NEXT POST →
Exciting Announcement: MORSE Consulting Welcomes Ben Faienza as Strategic Advisor

Contact Us

MORSE Consulting Inc.

Toronto | Ottawa, Canada

+1-647-717-3179 (Toronto)

+1-613-864-8645 (Ottawa)

info@morseconsulting.ca

NEW A one-day interactive training and scenario-based modelling experience!
A one-day interactive training and scenario-based modelling experience!
Order 2025 Report

2025 Canadian Reimbursement and Forecasting Timelines Report

Newsletter – MORSE Signals
Sign up for our free e-mail newsletter service and receive timely and relevant updates related to the emerging developments in the Canadian pharmaceutical reimbursement landscape.

Sign Up
Social
Connect & Follow:
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2023 MORSE Consulting Inc. All rights reserved. | Site by Directica Media
MORSE Consulting Releases its pCPA Quarterly Update – Q3 2023
Learn More
Learn More